Asia presents huge commercial opportunity to the global pharma market. However this potential can only be realized with successful regulatory approval.
The 5th Annual Pharmaceutical Regulatory Affairs Asia 2012 covers topics such as:
The 5th Annual Pharmaceutical Regulatory Affairs Asia 2012 brings together attendees from Pharmaceutical / Generics / Biopharmaceuticals companies, Regulatory authorities (government) & Ministry of Health, Clinical Research Organizations / Consultancies and Medical Devices / Diagnostics Companies.